Carson Wealth (CWM LLC)
RVMD icon

Carson Wealth (CWM LLC)’s Revolution Medicines RVMD Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$109K Buy
1,116
+414
+59% +$41.8K ﹤0.01% 3193
2025
Q4 		$56K Buy
702
+239
+52% +$15.7K ﹤0.01% 3521
2025
Q3 		$22K Sell
463
-454
-50% -$17.8K ﹤0.01% 4077
2025
Q2 		$34K Buy
917
+579
+171% +$22.2K ﹤0.01% 3561
2025
Q1 		$12K Sell
338
-154
-31% -$6.25K ﹤0.01% 4022
2024
Q4 		$22K Buy
492
+228
+86% +$11.5K ﹤0.01% 3380
2024
Q3 		$12K Buy
264
+33
+14% +$1.44K ﹤0.01% 3693
2024
Q2 		$9K Buy
231
+71
+44% +$2.65K ﹤0.01% 3625
2024
Q1 		$5K Hold
160
– – ﹤0.01% 3686
2023
Q4 		$5K Buy
160
+29
+22% +$697 ﹤0.01% 3539
2023
Q3 		$4K Buy
131
+11
+9% +$326 ﹤0.01% 3595
2023
Q2 		$3K Buy
120
+114
+1,900% +$2.8K ﹤0.01% 3685
2023
Q1 		$0 Buy
+6
New +$148 ﹤0.01% 4311

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Carson Wealth (CWM LLC)'s RVMD Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Revolution Medicines (RVMD) stake by 59% in Q1 2026, buying an estimated $41.8K and bringing the position to 1,116 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #3193.

Carson Wealth (CWM LLC) first reported a position in RVMD in Q1 2023 and has held it in 13 quarters since. 514 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,116 shares of Revolution Medicines worth $109K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 414 Revolution Medicines shares in Q1 2026, an estimated $41.8K.
  • Revolution Medicines made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3193 holding.
  • Carson Wealth (CWM LLC) first reported a position in Revolution Medicines in Q1 2023 and has held it in 13 quarters since.
  • 514 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.